Effect of pre-medication on early adverse reactions following antivenom use in snakebite: A systematic review and meta-analysis

Drug Safety

Volumn 34, Issue 10, 2011, Pages 869-880

  Habib, Abdulrazaq G ^a  

^a BAYERO UNIVERSITY   (Nigeria)

Author keywords

Antihistamines; Antivenins; Corticosteroids; Epinephrine; Meta analysis; Snake venom poisoning

Indexed keywords

ADRENALIN; CHLORPHENIRAMINE; DIPHENHYDRAMINE; HYDROCORTISONE; PLACEBO; PROMETHAZINE; SNAKE VENOM ANTISERUM;

ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DRUG INDUCED DISEASE; EARLY ADVERSE REACTION; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; PEER REVIEW; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SNAKE; SNAKEBITE; SYSTEMATIC REVIEW; TACHYCARDIA;

ANTIVENINS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOLOGIC FACTORS; SNAKE BITES; TIME FACTORS;

EID: 80052310299     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11592050-000000000-00000     Document Type: Article

References (38)

1. Gawarammana IB, Kularatne SA, Dissanayake W, et al. Parallel infusion of hydrocortisone-chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites: a randomised, double-blind, placebocontrolled study. Med J Aust 2004; 180 (1): 20-3 (Pubitemid 38049309)
2. Malasit P, Warrell DA, Chanthavanich P, et al. Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. BMJ 1986; 292 (6512): 17-20 (Pubitemid 16175877)
3. Fan HW, Marcopito LF, Cardoso JLC, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ 1999; 318 (7196): 1451-3 (Pubitemid 29243703)
4. Premawardhena AP, de Silva CE, Fonseka MMD, et al. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ 1999; 318 (7190): 1041-3 (Pubitemid 29191895)
5. Nuchpraryoon I, Garner P. Interventions for preventing reactions to snake antivenom. Cochrane Database Syst Rev 2000; (2): CD002153
6. Ball DE, Tisocki K. Prophylaxis against early anaphylactic reactions to snake antivenom: stopping trials early may result in insufficient evidence being accrued. BMJ 1999; 319 (7214): 920-1 (Pubitemid 29457431)
7. Caron EJ, Manock SR, Maudlin J, et al. Apparent marked reduction in early antivenom reactions compared to historical controls: was it prophylaxis or method of administration? Toxicon 2009; 54 (6): 779-83
8. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1-12 (Pubitemid 26120810)
9. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-60
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7 (3): 177-88 (Pubitemid 17189972)
11. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev 1992; 14: 154-76 (Pubitemid 23024558)
12. Tobias A. Assessing the influence of single study in the metaanalysis estimate (sb26). Stata Tech Bull 1999; 47: 15-7
13. Begg CB, MazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50 (4): 1088-101
14. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-34 (Pubitemid 27387172)
15. Lau J, Ioannidis JP, Terrin N, et al. The case of the misleading funnel plot. BMJ 2006; 333: 597-600 (Pubitemid 44433638)
16. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999; 354: 1896-900
17. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for writing. JAMA 2000; 283 (15): 2008-12 (Pubitemid 30214957)
18. Sutherland SK. Antivenom use in Australia: premedication, adverse reactions and the use of venom detection kits. Med J Aust 1992; 157 (11-12): 734-9 (Pubitemid 23009102)
19. Bucaretchi F, Douglas JL, Fonseca MR, et al. Snake bites in children: antivenom early reaction frequency in patients pretreated with histamine antagonists H1 and H2 and hydrocortisone. Rev Inst Med Trop Sao Paulo 1994; 36 (5): 451-7 (Pubitemid 24360480)
20. Zafar J, Aziz S, Hamid B, et al. Snake bite experience at Pakistan Institute of Medical Sciences. J Pak Med Assoc 1998; 48 (10): 308-10 (Pubitemid 128706112)
21. Sutherland SK. A life-threatening anaphylactoid reaction to polyvalent antivenom despite pretreatment. Med J Aust 1999; 170 (2): 92-3 (Pubitemid 29037681)
22. Chen JC, Bullard MJ, Chiu TF, et al. Risk of immediate effects from F(ab)2 bivalent antivenin in Taiwan. Wilderness Environ Med 2000; 11 (3): 163-7
23. Kularatne SAM. Reaction to snake venom antisera: study of pattern, severity, and management at General Hospital, Anuradhapura. Sri Lanka J Med 2000; 9: 8-13
24. Dassanayake AS, Karunanayake P, Kasturiratne KTA, et al. Safety of subcutaneous adrenaline as prophylaxis against acute adverse reactions to anti-venom serum in snakebite. Ceylon Med J 2002; 47 (2): 48-9
25. Brown SG. Parallel infusion of hydrocortisone-chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites [letter]. Med J Aust 2004; 180 (8): 428
26. Cheng AC, Winkel KD. Antivenom efficacy, safety and availability: measuring smoke.Med J Aust 2004; 180 (1): 5-6 (Pubitemid 38049305)
27. Williams DJ, Jensen SD, Nimorakiotakis B, et al. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural PapuaNew Guinea. Toxicon 2007; 49 (6): 780-92 (Pubitemid 46590248)
28. Isbister GK, Brown SG, MacDonald E, et al. Current use of Australian snake antivenoms and frequency of immediatetype hypersensitivity reactions and anaphylaxis. Med J Aust 2008; 188 (8): 473-6
29. Seneviratne SL, Opanayaka CJ, Ratnayake NS, et al. Use of antivenom serum in snake bite: a prospective study of hospital practice in the Gampaha district. Ceylon Med J 2000; 45 (2): 65-8
30. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114 (2): 371-6 (Pubitemid 39119039)
31. Lin RY, Curry A, Pesola GR, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 anatagonists. Ann Emerg Med 2000; 36 (5): 462-8
32. Meyer WP, Habib AG, Onayade AA, et al. First clinical experiences with a new ovine FAB Echis ocellatus snakebite antivenom in Nigeria: randomised comparative trial with institute pasteur serum (IPSer) Africa antivenom. Am J Trop Med Hygiene 1997; 56 (3): 291-300 (Pubitemid 27181015)
33. Chippaux J-P, Lang J, Amadi Eddine S, et al. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. Trans R Soc Trop Med Hyg 1998; 92 (6): 657-62 (Pubitemid 29015222)
34. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa andNorth America. JAMA 2006; 296 (6): 679-90 (Pubitemid 44200639)
35. Balcells ME, Thomas SL, Godfrey-Fausett P, et al. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis 2006; 12 (5): 744-51 (Pubitemid 43726847)
36. Martyn-St James M, Carroll S. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women. Bone 2008; 43: 521-31
37. Kwok CS, Nijjar RS, Loke YK. Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis. Drug Saf 2011; 34 (1): 47-57
38. Chippaux JP, Stock RP, Massougbodji A. Methodology of clinical studies dealing with the treatment of envenomation. Toxicon 2010; 55 (7): 1195-212